TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
Slide background
  • June 18, 2019

ARLINGTON HEIGHTS, IL—In the last five years, the number of US allergists prescribing sublingual immunotherapy (SLIT) tablets rather than the more traditional allergy shots has grown, according to a study published by the American College of Allergy, Asthma, and Immunology (ACAAI) Immunotherapy and Diagnostics committee. The organization sent out an electronic survey to US and international allergists who are also ACAAI members and compared the results with previous surveys conducted and published in 2007 and 2011. Of the 305 respondents, 268 (87.9 percent) practiced in the US and of those 268 US allergists, 197 (73.5 percent) reported prescribing SLIT to patients, showing a significant increase compared to the 2007 (5.9 percent) and 2011 (11.4 percent) surveys. This growing use of SLIT prescriptions may have been driven by four recent FDA-approved SLIT options.